In the Pharmaceuticals & Drugs sector, Syncom Formulations (India) Ltd. shows a mixed performance with notable growth in revenue, but lower profitability and efficiency metrics compared to peers. Companies like Cipla Ltd. and Dr. Reddy's Laboratories Ltd. lead in profitability, while Syncom appears to be overvalued relative to its peers' financial health and growth potential.

• • Cipla Ltd. and Dr. Reddy's Laboratories Ltd. are the most profitable with the highest ROE and EPS.
• • Syncom has the lowest profitability metrics and is overvalued with a PE ratio of 32.28 compared to peers.
• • Cipla is the best value pick with low PE and high profitability ratios.